ViAn Therapeutics
Protecting sight with a simple eye drop.
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2023
- Business Model
- B2B
- Website
- viantx.com
- Total Funding
- $275K
- Last Round
- $275K SeedOct 2023
About
VIAN Therapeutics is a virtual pharma startup developing a topical antiangiogenic eye drop (VIAN-001) to treat retinal vascular diseases including AMD and diabetic macular edema. Their lead compound inhibits VEGF and Ang-2 to prevent pathological angiogenesis and vascular permeability. The company is backed by IndieBio and founded by Dr. Juan Pablo Robles.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account